{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:14:13Z","timestamp":1790493253509,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1038\/sj.cdd.4400813","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T17:35:52Z","timestamp":1032284152000},"page":"273-278","source":"Crossref","is-referenced-by-count":43,"title":["CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies"],"prefix":"10.1038","volume":"8","author":[{"given":"J","family":"Str\u00e4ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Melzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Leith\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,4,23]]},"reference":[{"key":"BF4400813_CR1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda T, Takahashi T, Golstein P, Nagata S . 1993 Molecular cloning and expression of the Fas ligand, a novel member of the Tumor Necrosis Factor family Cell 75: 1169\u20131178","journal-title":"Cell"},{"key":"BF4400813_CR2","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/intimm\/6.10.1567","volume":"10","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S . 1994 Human Fas ligand: gene structure, chromosomal location and species specificity Int. Immunol. 10: 1567\u20131574","journal-title":"Int. Immunol."},{"key":"BF4400813_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0952-7915(96)80125-7","volume":"8","author":"L van-Parijs","year":"1996","unstructured":"van-Parijs L, Abbas -AK . 1996 Role of Fas-mediated cell death in the regulation of immune responses Curr. Opin. Immunol. 8: 355\u2013361","journal-title":"Curr. Opin. Immunol."},{"key":"BF4400813_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0167-5699(97)81663-5","volume":"18","author":"TS Griffith","year":"1997","unstructured":"Griffith TS, Ferguson TA . 1997 The role of FasL-induced apoptosis in immune privilege Immunol. Today 18: 240\u2013244","journal-title":"Immunol. Today"},{"key":"BF4400813_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0167-5699(98)01382-6","volume":"20","author":"J O'Connell","year":"1999","unstructured":"O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F . 1999 The Fas counterattack: cancer as a site of immune privilege Immunol. Today 20: 46\u201352","journal-title":"Immunol. Today"},{"key":"BF4400813_CR6","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1126\/science.279.5359.2015a","volume":"279","author":"TA Stokes","year":"1998","unstructured":"Stokes TA, Rymaszewski M, Arscott PL, Wang SH, Bretz JD, Bartron J, Baker Jr JR . 1998 Constitutive expression of FasL in thyrocytes Science 279: 2015","journal-title":"Science"},{"key":"BF4400813_CR7","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1126\/science.279.5359.2015a","volume":"279","author":"P Fiedler","year":"1998","unstructured":"Fiedler P, Schaetzlien CE, Eibel H . 1998 Constitutive expression of FasL in thyrocytes Science 279: 2015","journal-title":"Science"},{"key":"BF4400813_CR8","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.160.9.4159","volume":"160","author":"D Smith","year":"1998","unstructured":"Smith D, Sieg S, Kaplan D . 1998 Aberrant detection of cell surface Fas ligand with anti-peptide antibodies J. Immunol. 160: 4159\u20134160","journal-title":"J. Immunol."},{"key":"BF4400813_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.cdd.4400622","volume":"7","author":"P Fiedler","year":"2000","unstructured":"Fiedler P, Eibel H . 2000 Antibody mAb33 from Transduction Laboratories detects human CD95L in ELISA but not in immunoblots Cell Death Differ. 7: 126\u2013128","journal-title":"Cell Death Differ."},{"key":"BF4400813_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.cdd.4400644","volume":"7","author":"JR Baker Jr","year":"2000","unstructured":"Baker Jr JR, Bretz JD . 2000 Specificity questions concerning the clone 33 anti-fas ligand antibody Cell Death Differ. 7: 8\u20139","journal-title":"Cell Death Differ."},{"key":"BF4400813_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9440(10)65265-0","volume":"154","author":"J Str\u00e4ter","year":"1999","unstructured":"Str\u00e4ter J, Mariani SM, Walczak H, R\u00fccker FG, Leith\u00e4user F, Krammer PH, M\u00f6ller P . 1999 CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L Am. J. Pathol. 154: 193\u2013201","journal-title":"Am. J. Pathol."},{"key":"BF4400813_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.275.5302.960","volume":"275","author":"C Giordano","year":"1997","unstructured":"Giordano C, Stassi G, DeMaria R, Toldaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A . 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis Science 275: 960\u2013963","journal-title":"Science"},{"key":"BF4400813_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.cdd.4400623","volume":"7","author":"I Herr","year":"2000","unstructured":"Herr I, Posovsky C, Bohler T, Debatin K-M . 2000 mAb 33 from Transduction Laboratories specifically binds to human CD95-L Cell Death Differ. 7: 129\u2013130","journal-title":"Cell Death Differ."},{"key":"BF4400813_CR14","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","volume":"16","author":"H Walczak","year":"1997","unstructured":"Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT . 1997 TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J. 16: 5386\u20135397","journal-title":"EMBO J."},{"key":"BF4400813_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<524::AID-CNCR5>3.0.CO;2-U","volume":"88","author":"M Younes","year":"2000","unstructured":"Younes M, Schwartz MR, Ertan A, Finnie D, Younes A . 2000 Fas ligand expression in esophageal carcinomas and their lymph node metastases Cancer 88: 524\u2013528","journal-title":"Cancer"},{"key":"BF4400813_CR16","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.4049\/jimmunol.160.11.5669","volume":"160","author":"MW Bennett","year":"1998","unstructured":"Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F . 1998 The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinomas J. Immunol. 160: 5669\u20135675","journal-title":"J. Immunol."},{"key":"BF4400813_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gut.44.2.156","volume":"44","author":"MW Bennett","year":"1999","unstructured":"Bennett MW, O'Connell J, O'Sullivan GC, Roche D, Brady C, Kelly J, Collins JK, Shanahan F . 1999 Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer Gut 44: 156\u2013162","journal-title":"Gut"},{"key":"BF4400813_CR18","first-page":"9","volume":"149","author":"P M\u00f6ller","year":"1996","unstructured":"M\u00f6ller P, Walczak H, Riedl S, Str\u00e4ter J, Krammer PH . 1996 Paneth cells express high levels of CD95 ligand transcripts. A unique property among gastrointestinal epithelia Am. J. Pathol. 149: 9\u201313","journal-title":"Am. J. Pathol."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/4400813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4400813","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4400813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:16:49Z","timestamp":1684369009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4400813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["BF4400813"],"URL":"https:\/\/doi.org\/10.1038\/sj.cdd.4400813","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}